Evidence map›Paper›PMID 30261642›Full record

ArticleMaterials (Basel, Switzerland)2018

Characterization and Preliminary Biological Evaluation of 3D-Printed Porous Scaffolds for Engineering Bone Tissues.

Chen-Guang Liu, Yu-Ting Zeng, Ranjith Kumar Kankala, Shan-Shan Zhang, Ai-Zheng Chen, Shi-Bin Wang

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Bone Tissue Engineering in the Treatment of Bone Defects.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Article
  8. Poly(lactic-Bioactive materials · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chen-Guang LiuInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China. 1611315017@hqu.edu.cn.ORCID 0000-0001-5999-8870
Yu-Ting ZengInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China. 1400215025@hqu.edu.cn.
Ranjith Kumar KankalaInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China. ranjithkankala@hqu.edu.cn.ORCID 0000-0003-4081-9179
Shan-Shan ZhangInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China. 1611315042@hqu.edu.cn.
Ai-Zheng ChenInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China. azchen@hqu.edu.cn.ORCID 0000-0002-5840-3406
Shi-Bin WangInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China. sbwang@hqu.edu.cn.

Funding

National Key R&D Program of China 2018YFB1105600Natural Science Foundation of China U1605225, 31570974, and 31470927Promotion Program for Young and Middle-Aged Teachers in Science and Technology Research of Huaqiao University ZQN-PY107Public Science and Technology Research Funds Projects of Ocean 201505029Start-up grant from Huaqiao University 16BS803
6 · The paper itself

Abstract

Some basic requirements of bone tissue engineering include cells derived from bone tissues, three-dimensional (3D) scaffold materials, and osteogenic factors. In this framework, the critical architecture of the scaffolds plays a crucial role to support and assist the adhesion of the cells, and the subsequent tissue repairs. However, numerous traditional methods suffer from certain drawbacks, such as multi-step preparation, poor reproducibility, high complexity, difficulty in controlling the porous architectures, the shape of the scaffolds, and the existence of solvent residue, which limits their applicability. In this work, we fabricated innovative poly(lactic-

Indexed as

3D-printingbiodegradationosteoblast growthpoly(lactide-co-glycolide)tissue engineering

Identifiers

PMID30261642
PMCPMC6213437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.